Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Nutrition quality should be prioritized over restriction, especially in patients using GLP-1 therapies
In the phase III STEP 6 trial conducted in Japan and South Korea, semaglutide 2.4 mg resulted in a mean percentage change in body weight from baseline to week 68 of -13.2% (standard error [SE] 0.5), compared with -2.1% (SE 0.8) achieved with placebo, corresponding to a between-group difference of -11.1% (95% confidence interval [CI], -12.9 to -9.2) using the treatment policy estimand
Healthcare providers typically prescribe GLP-1 medications using a step-wise approach, starting with lower doses and increasing gradually over several weeks
A patient shared: I had plateaued in my weight loss journey
Ora's GLP-1 Up supports stable blood sugar, fights food noise, & promotes health body composition.
